| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3237338
Max Phase: Preclinical
Molecular Formula: C24H18Br2N2O2
Molecular Weight: 526.23
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1cc(C(c2c[nH]c3ccc(Br)cc23)c2c[nH]c3ccc(Br)cc23)ccc1O
Standard InChI: InChI=1S/C24H18Br2N2O2/c1-30-23-8-13(2-7-22(23)29)24(18-11-27-20-5-3-14(25)9-16(18)20)19-12-28-21-6-4-15(26)10-17(19)21/h2-12,24,27-29H,1H3
Standard InChI Key: ZFXSMNBVJSKGKL-UHFFFAOYSA-N
Associated Targets(non-human)
Beta-glucuronidase 291 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 526.23 | Molecular Weight (Monoisotopic): 523.9735 | AlogP: 7.07 | #Rotatable Bonds: 4 |
| Polar Surface Area: 61.04 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
| #RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 9.91 | CX Basic pKa: | CX LogP: 6.76 | CX LogD: 6.76 |
| Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.23 | Np Likeness Score: 0.05 |
References
| 1. Khan KM, Rahim F, Wadood A, Taha M, Khan M, Naureen S, Ambreen N, Hussain S, Perveen S, Choudhary MI.. (2014) Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies., 24 (7): [PMID:24602903] [10.1016/j.bmcl.2014.02.015] |
Source
Source(1):